To avoid system errors, if Chrome is your preferred browser, please update to the latest version of Chrome (81 or higher) or use an alternative browser.
Click here to login if you're an NAE Member
Recover Your Account Information
Download File (mp3)
Please upgrade to a newer browser.
Anchor Lead: There’s a new weapon in the fight against ovarian cancer…math.
Randy Atkins: Using massive databases with genetic information about cells of ovarian cancer patients, Orly Alter, a bioengineer at the University of Utah, says she’s found a way to determine in advance how well a patient will respond to the standard medications.
Orly Alter: Our mathematics…enabled us to discover variations in the biochemistry of the tumors that correlate with the patient outcome.
Randy Atkins: It may lead to test that can, for the first time, both predict treatment effectiveness and offer a prognosis. Alter says the new mathematical technique has also uncovered potential new targets for drugs, so...
Orly Alter: …maybe a combination of those drugs that already exist might be relevant for ovarian cancer.
Randy Atkins: Another step toward personalizing medicine. With the National Academy of Engineering, Randy Atkins, WTOP News.
Anchor Tag: The test isn’t available yet, but could be in ready in about two years.